Cassava Sciences Inc SAVA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:17 PM EST
55.16quote price arrow down-0.80 (-1.44%)
Volume
1,146,127
52 week range
6.70 - 146.16
Loading...
  • Open57.36
  • Day High58.63
  • Day Low54.61
  • Prev Close55.96
  • 52 Week High146.16
  • 52 Week High Date07/29/21
  • 52 Week Low6.70
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap2.207B
  • Shares Out40.01M
  • 10 Day Average Volume5.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change729.33

KEY STATS

  • Open57.36
  • Day High58.63
  • Day Low54.61
  • Prev Close55.96
  • 52 Week High146.16
  • 52 Week High Date07/29/21
  • 52 Week Low6.70
  • 52 Week Low Date12/29/20
  • Market Cap2.207B
  • Shares Out40.01M
  • 10 Day Average Volume5.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change729.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.55
  • P/E (TTM)-100.69
  • Fwd P/E (NTM)-151.53
  • EBITDA (TTM)-12.721M
  • ROE (TTM)-8.45%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/21/2022
  • Ex Div Date12/13/2010
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest On Cassava Sciences Inc

Content From Our Affiliates

Profile

MORE
Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead therapeutic product candidate, Simufilam, is a proprietary small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimers brain. The SavaDx, is an early-stage program focused...
Remi Barbier
Chairman
Eric Schoen
Chief Financial Officer
Address
7801 N Capital of Texas Hwy Ste 260
Austin, TX
78731-1192
United States

Top Peers

SYMBOLLASTCHG%CHG
EDIT
Editas Medicine Inc
31.84-0.53-1.63%
IBRX
Immunitybio Inc
6.44-0.06-0.92%
CLDX
Celldex Therapeutics Inc
39.08-0.54-1.35%
RVMD
Revolution Medicines Inc
27.30+0.28+1.04%
NUVB
Nuvation Bio Inc
8.88+0.71+8.69%